Page 10 - EASL POSTGRADUATE COURSE

WEDNESDAY, APRIL 22, 2015 (CONT.)

NAFLD and interactions with insulin resistance 14:00 - 15:40

14:00 Q&A (QUESTIONS)
Case presentation

Pierre-Emmanuel Rautou, France

14:15 Excessive body weight and risk of NASH: are all obese patients
equal?

Amalia Gastaldelli, Italy

14:35 Insulin resistance: should we measure it and does it promote liver
disease progression?

Elisabetta Bugianesi, Italy

14:55 Dysmetabolic hyperferritinemia
Yves Deugnier, France

15:15 Bariatric surgery: a cure for NASH?
Carel Le Roux, Ireland

15:35 Q&A (ANSWERS)

15:40 - 16:00 Coffee break

Extrahepatic complications of liver fat 16:00 - 17:40

16:00 Q&A (QUESTIONS)
Case presentation

Fabio Nascimbeni, Italy

16:15 Why does liver fat contribute to cardio-metabolic outcomes?
Hannele Yki-Jarvinen, Finland

16:35 NAFLD, pre-atherogenic lesions and cardiovascular events
Sven M.A. Francque, Belgium

16:55 Does steatosis place patients at risk for diabetes development and
progression?

Naveed Sattar, The United Kingdom

17:15 Current and future insulin sensitizers in the treatment of NASH
Vlad Ratziu, France

17:35 Q&A (ANSWERS)

10 Postgraduate Course Syllabus • Metabolic Liver Disease